A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis

Stopped early · Phase 2

Conditions studied: Distal Subungual Onychomycosis

In brief

The purpose of this study is to determine if a local treatment is effective for the treatment of toenail fungus (distal subungual onychomycosis).

Key facts

Study ID

NCT01093118

Run by

Talima Therapeutics, Inc.

People needed

120

Starts

2009-09-01

Last updated by the study team

2011-01-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female, 18 to 75 years of age, inclusive
• Diagnosed with distal subungual onychomycosis (DSO) of the toenails
• Great toe(s) with intact skin and intact neurologic functions
• Great toenail(s) free of nail polish
• At least one target great toe which has:
• 25 to 75% involvement of the area of the nail unit (including destroyed or missing parts of the nail plate)
• at least 2 mm of uninvolved nail growth as measured from the proximal nail fold to the most proximal point to the disease process and with no lunular involvement
• nail unit hyperkeratosis at the most distal edge which measures no greater than 3 mm
• a positive KOH and culture

You may not qualify if…

• Any significant disease of the hepatic, renal, endocrine (including diabetes mellitus), immune systems, or other health conditions which could interfere with or confound the results of study assessments
• Pre-existing chronic foot pain, neurologic deficit or skin disease/injury in treated foot
• In the case of female subjects, are pregnant, nursing, or planning to become pregnant within the study period
• History of clinically significant abnormal laboratory values, including liver function test results equal to or greater than 2 x the upper limit of normal
• Disease-like psoriatic toenails, significant toenail abnormalities/dystrophies, toenail injuries or any other condition in the toenail which could interfere with study evaluations (e.g., prevent obtaining normal appearing nail, after clearing of onychomycosis, due to chemical damage, genetic or pigmentary disorders, etc.)
• Have white superficial onychomycosis, proximal subungual onychomycosis, yellow spikes, or dermatophytoma
• Have paronychia
• Have a history of chronic alcohol or drug abuse

Where it is running

• Radiant Research, Inc. — Tucson, Arizona, United States
• Therapeutics Clinical Research — San Diego, California, United States
• International Dermatology Research Center — Miami, Florida, United States
• Radiant Research, Inc. — Cincinnati, Ohio, United States
• Oregon Medical Research Center — Portland, Oregon, United States
• J&S Studies, Inc. — College Station, Texas, United States
• Dermatology Research Center — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.